What is this medicine used for?
FDA-approved uses
- Attention-deficit/hyperactivity disorder (ADHD) — Adults and children aged 6 years and older. Used within a broader treatment plan. Use below age 6 is not recommended because exposure and adverse effects were greater in younger children.Vyvanse capsules; Vyvanse chewable tablets.
- Moderate to severe binge eating disorder — Adults. This approval does not cover obesity, ordinary overeating or weight loss. Pediatric binge eating disorder use is not established.Vyvanse capsules; Vyvanse chewable tablets.
Read more: ADHD.
What should I expect?
For ADHD, benefit can be present during the day a dose is taken, but finding the right treatment plan and reviewing appetite, sleep, and heart effects takes follow-up. For binge eating disorder, progress means fewer binge-eating episodes over time, not simply a reduced appetite or weight loss.
Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.
How do I take it safely?
Take in the morning with or without food; afternoon doses can disturb sleep. Chew chewable tablets thoroughly. Capsules may be swallowed whole or their entire contents mixed with yogurt, water, or orange juice and taken immediately. Do not split a capsule dose or store the mixture.
Keep it securely stored and never share it. Before and during treatment, review misuse risk, heart history, blood pressure, pulse, mood, tics, and painful or discolored fingers or toes. Children need height and weight checks; kidney impairment may change the dose limit.
Allergy to amphetamine products or product ingredients. Current MAOI use or use within 14 days after stopping an MAOI.
The label advises avoiding use in serious structural heart disease, serious rhythm disorders, or other serious heart disease.
MAO inhibitors can produce a dangerous blood-pressure reaction. Serotonergic medicines and strong CYP2D6 inhibitors can increase the risk of serotonin syndromeSerotonin syndromeSerotonin syndrome (also called serotonin toxicity) is a potentially life-threatening drug reaction caused by excessive serotonin activity in the nervous system.It can develop soon after starting or increasing a serotonin-affecting medicine, or combining it with another medicine or substance that affects serotonin.Possible signs include agitation or confusion, sweating, fever, diarrhea, shaking, and stiff or twitching muscles.Seek urgent medical help if you suspect serotonin syndrome. Severe symptoms, such as a high fever, seizures, or loss of consciousness, need emergency care.; signs include fever, confusion, agitation, muscle stiffness or twitching and unstable pulse. Medicines that change urine acidity can change amphetamine exposure. Do not use supplements or antacids to alter the medicine’s effects. Review all prescribed medicines, nonprescription products and supplements with the pharmacist.
Pregnancy data are insufficient to establish a precise drug-associated risk; stimulant effects and untreated illness both matter in an individual discussion. The Vyvanse label recommends against breastfeeding during treatment because amphetamine enters milk and serious infant effects are possible.
ADHD approval starts at age 6; binge eating disorder approval is for adults. Younger children can have higher drug exposure and more adverse reactions. Older adults were insufficiently represented in trials and may need particular attention to kidney, cardiovascular and medication-interaction risks.
Do not double a missed dose. Because the label discourages afternoon dosing, ask the pharmacist how to handle a late remembered dose. Discuss stopping with the prescriber; abrupt discontinuation or large reduction after prolonged stimulant use can cause depressed mood, fatigue, sleep changes and increased appetite.
What side effects should I know about?
- Reduced appetite and weight, dry mouth, nausea or abdominal discomfort.
- Insomnia, anxiety, irritability, jitteriness and increased heart rate.
- Vyvanse is not approved or recommended for children younger than 6. Studies found higher drug exposure and more adverse effects, including weight loss, in this age group. Children taking it need height and weight monitoring; report poor appetite, weight loss or slowed growth to the prescriber.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)Vyvanse capsules and chewable tablets
Which warning signs need help?
- Chest pain, fainting, severe shortness of breath or an irregular heartbeat need urgent assessment.
- High fever with confusion, agitation, muscle stiffness or twitching may indicate serotonin syndromeSerotonin syndromeSerotonin syndrome (also called serotonin toxicity) is a potentially life-threatening drug reaction caused by excessive serotonin activity in the nervous system.It can develop soon after starting or increasing a serotonin-affecting medicine, or combining it with another medicine or substance that affects serotonin.Possible signs include agitation or confusion, sweating, fever, diarrhea, shaking, and stiff or twitching muscles.Seek urgent medical help if you suspect serotonin syndrome. Severe symptoms, such as a high fever, seizures, or loss of consciousness, need emergency care..
- New hallucinationsHallucinationsA hallucination is a sensory experience without a corresponding external source—for example, hearing a voice when nobody is speaking. It can involve hearing, sight, touch, smell or taste and may feel very real.A hallucination is an experience; a delusion is a belief. Hallucinations can have different causes, so an assessment is needed to understand them. or mania, severe allergic swelling, seizures or suspected overdose require urgent medical help.
- Get emergency help for trouble breathing, collapse, a seizure, or severe or rapidly worsening symptoms. If thoughts of self-harm put you in immediate danger, seek emergency care now.
What else should I know to stay safe?
- Store securely and never share. Do not use after an amphetamine allergy or within 14 days after an MAOI. Avoid use in serious heart disease. Monitor blood pressure, pulse, mood, tics, and circulation in fingers or toes; children also need height and weight checks.
- Serotonin-affecting medicines, strong CYP2D6 inhibitors, and medicines that change urine acidity can alter risk or exposure. Do not use supplements or antacids to intensify the effect. Kidney impairment can change dose limits, and abrupt reductions after prolonged use can cause withdrawal; arrange changes with the prescriber.
- Discuss pregnancy and breastfeeding. The Vyvanse label recommends against breastfeeding during treatment because amphetamine enters milk. ADHD approval begins at age 6 and binge eating disorder approval is adult only; older adults may have additional heart, kidney, and interaction risks.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- A prodrug still has stimulant risks. Conversion in the body does not make Vyvanse free of misuse, addiction, or overdose risk.
- Reduced appetite is a side effect, not the treatment goal. For ADHD, follow attention and daily functioning; for binge eating disorder, follow binge episodes and the wider recovery plan.
How does it work?
The body converts lisdexamfetamine into dextroamphetamine, the active stimulant. This changes the handling of dopamine and norepinephrine, chemical messengers used by nerve cells. The conversion and messenger effects are established, but the complete link to symptom improvement is not known.
Explore more in Brain & Science: Stimulant Transport and Release: Amphetamine.
How was this medicine developed?
The FDA approved Vyvanse capsules in 2007. Its prodrug design means the body converts it to the active stimulant dextroamphetamine. Later approvals added chewable tablets and adult binge eating disorder treatment.
How do I say the name?
Lisdexamfetamine: lis-dex-am-FET-uh-meen. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
Vyvanse capsules
Use only the selected US product labeling; formulation and jurisdiction scope are explicit.
Vyvanse chewable tablets
Use only the selected US product labeling; formulation and jurisdiction scope are explicit.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Vyvanse: current product prescribing information
- Lisdexamfetamine: patient information
- Vyvanse capsules: FDA approval and product record
- Vyvanse: FDA prescribing information, April 2026
- Vyvanse: Package Insert / Prescribing Information / MOA
- Vyvanse chewable tablets: FDA approval and product record
- Concerta: prescribing information
- Atomoxetine: FDA prescribing information
- Serotonin syndrome: MedlinePlus Medical Encyclopedia
- Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
- Schizophrenia
- NIMH: Understanding psychosis
Giving medicine safely to children: family guide (PDF, 3 pages)

